[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"knee-range-of-motion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:knee-range-of-motion":71},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100582447","mymobility-knee-rom-100582447",false,"NCT06863428","Mymobility Knee ROM","Concordance Between an App-based Range of Motion Measurement and Standard Goniometer.","Inclusion Criteria:\n\n* Patient is a minimum of 18 years of age\n* Patient is willing and able to provide written Informed Consent by signing and dating the IRB-approved Informed Consent form\n\nExclusion Criteria:\n\n* The patient is currently participating in any other study that would hinder the assessor's ability to measure knee ROM\n* Complex primary knee pathology with significant restrictions on the range of motion per surgeon discretion\n* Patient is pregnant or considered a member of a protected population (e.g. prisoner, mentally incompetent, etc.)",true,"ALL","18 Years",{"count":20,"type":21},41,"ESTIMATED","OBSERVATIONAL","This prospective study aims to evaluate the agreement, also referred as concordance, of the mymobilty knee ROM with a clinician's assessment of knee ROM via goniometer.",[25],"Knee Range of Motion",[27,28,29],"mymobility","range of motion","goniometer","RECRUITING","2026-01-15",{"date":33,"type":34},"2026-01-20","ACTUAL",{"date":36,"type":34},"2025-11-21",{"date":38,"type":21},"2026-07-01",{"name":40,"class":41},"Zimmer Biomet","INDUSTRY",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":42},"100602514","regional-anesthesia-in-tka-impact-on-postoperative-joint-motion-and-patient-satisfaction-100602514","NCT07124494","Regional Anesthesia in TKA: Impact on Postoperative Joint Motion and Patient Satisfaction","Evaluation of the Effects of Regional Anesthesia Methods Applied in Total Knee Arthroplasty on Joint Range of Motion in the Postoperative Period and Patient Satisfaction","* Minimum Age: 18 Years\n* Maximum Age: None\n* Sex: All\n* Gender Based: No\n* Accepts Healthy Volunteers: No\n* Inclusion Criteria:\n\n  * Scheduled for primary total knee arthroplasty\n  * Age ≥ 18 years\n  * American Society of Anesthesiologists (ASA) physical status I-III\n  * Accepting neuraxial anesthesia\n* Exclusion Criteria:\n\n  * Skin infection at the planned injection site\n  * Sepsis\n  * Coagulopathy\n  * Refusal of neuraxial anesthesia\n  * Severe hypovolemia\n  * Demyelinating central nervous system disease\n  * Age under 18 years\n  * Illiterate in Turkish\n  * Non-cooperative patients\n  * Known allergy or hypersensitivity to bupivacaine",{"count":51,"type":21},30,"INTERVENTIONAL",[54],"NA","This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia\u002Fanalgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.",[57,58,59,25,60],"Total Knee Arthroplasty","Postoperative Pain","Regional Anesthesia","Patient Satisfaction","2025-08-21",{"date":63,"type":34},"2025-08-28",{"date":65,"type":34},"2025-08-05",{"date":67,"type":21},"2026-02-19",{"name":69,"class":70},"Konya City Hospital","OTHER","Knee Range-of-motion"]